MedTrace Logo

Outcome of BCF Access in Hemodialysis Patients

NCT01693263 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2026-05-12

No results posted yet for this study

Summary

Dialysis access, which is the connection that allows blood to flow in and out of the body during dialysis sessions, is important to remove wastes and excess fluid for patients with end stage renal disease (ESRD). One method used to access the vein and artery for dialysis is called a brachiocephalic fistula. Patients are being asked to participate in this study because they have endstage renal disease, and their doctor has recommended that they will have brachiocephalic fistula placed for their dialysis access.

A common problem seen in patients with a brachiocephalic fistula (BCF) is cephalic arch stenosis (CAS). CAS is a narrowing in the central vein (located in the upper chest). CAS causes problems with the opening of the veins and arteries needed for dialysis. Once someone suffers CAS they may need several radiology procedures as well as surgery to help correct the problem.

The BCF may fail once CAS develops.

The purpose of the research study is to gather information about the BCF and what is happening inside the vein. The researchers hope to find out what may be the cause of CAS.

Conditions

  • End Stage Renal Disease (ESRD)
  • Brachiocephalic Fistula (BCF)
  • Cephalic Arch Stenosis (CAS)
  • Dialysis

Interventions

OTHER

brachiocephalic fistula (BCF)

We will collect information from physical exams, blood tests, venogram, doppler, vein and artery tissue samples

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Illinois Institute of Technology

    collaborator OTHER

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Chicago

    lead OTHER

Principal Investigators

  • Mary Hammes, MD · University of Chicago

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01693263 on ClinicalTrials.gov